Scientifically, it's a cyclic heptapeptide with high affinity for MC4R (EC50 ~1 nM), making it highly specific for central arousal pathways.[4] It boosts desire, arousal, and lubrication through neurological activation, offering benefits like increased motivation and physical readinessdistinct from vascular drugs like sildenafil.[1][4][5] Studies show it improves HSDD symptoms, with 51% of women reporting significant desire boosts in phase 3 trials.[1] Biohacker Ben Greenfield has noted: "PT-141 enhances response efficiently, making it a go-to for biohacking intimacy without side effects of traditional meds."[17] For experts, its brain-targeted action avoids cardiovascular risks, positioning it as a versatile tool for HSDD, with preclinical data showing sustained dopamine release
Calms inflammation and supports lining repair
World J Immunol (2022) 12(2):1524
My advice to clinicians is to proactively discuss contraception when initiating GLP-1 therapies in women of child-bearing age, document pregnancy intentions, and give pre-conception wash-out advice as per FSRH guidelines, said Dr Cheung